Sehn LH, Bartlett NL, Matasar MJ, Schuster SJ, et al. Long-term 3-year follow-up of mosunetuzumab in relapsed or refractory follicular lymphoma after >/=2 prior therapies. Blood 2024 Oct 24:blood.2024025454. doi: 10.1182/blood.2024025454.
PMID: 39447094